Literature DB >> 1977852

Reduction of serum calcium by sodium sulfonated polystyrene resin.

Y Y Ng1, S C Wu, C T Cheng, W C Yang, H M Chung, T P Huang.   

Abstract

Sodium resin has been clinically administered against hyperkalemia widely, but its effects of lowering the serum calcium has never been documented. In our study, 7 patients with chronic renal failure were chosen at random to take sodium resin 30 g per day for 3 days. The sodium resin not only lowered the serum potassium level (p less than 0.05) but also brought down the level of serum calcium (p less than 0.05). The reduced ability of patients with chronic renal failure to absorb calcium from the gastrointestinal tract is well recognized, so its effects of lowering calcium will be more likely to aggravate the serum calcium imbalance further. If sodium resin has to be used for the maintainance of serum potassium in patients with chronic renal failure the serum calcium should be monitored closely in order to lighten the osteodystrophy and secondary hyperparathyroidism.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1977852

Source DB:  PubMed          Journal:  J Formos Med Assoc        ISSN: 0929-6646            Impact factor:   3.282


  2 in total

1.  Polysulfonate Resins in Hyperkalemia: A Systematic Review.

Authors:  Sheung Wing Sherwin Wong; Grace Zhang; Patrick Norman; Hasitha Welihinda; Don Thiwanka Wijeratne
Journal:  Can J Kidney Health Dis       Date:  2020-10-30

2.  Hypernatremia in a patient treated with sodium polystyrene sulfonate.

Authors:  Manish Nepal; Ion Dan Bucaloiu; Evan R Norfolk
Journal:  Int J Nephrol Renovasc Dis       Date:  2010-11-16
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.